Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 1/20 | 0.36 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.35 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811190 | 0.79 | POLB (0.39) | GABBR2GABBR1 | |
| SCHEMBL13626850 | 0.79 | DRD1 (0.35) | DRD1GABBR2GABBR1 | |
| SCHEMBL708320 | 0.78 | DRD1 (0.61) | DRD1GABBR2GABBR1 | |
| SCHEMBL21327677 | 0.76 | POLB (0.36) | GABBR2GABBR1 | |
| SCHEMBL14612293 | 0.76 | GABBR2 (0.39) | GABBR2GABBR1 | |
| SCHEMBL547487 | 0.76 | ALDH1A1 (0.39) | GABBR2GABBR1 | |
| SCHEMBL708899 | 0.76 | GABBR2 (0.36) | GABBR2GABBR1 | |
| SCHEMBL31462832 | 0.76 | POLB (0.36) | GABBR2GABBR1 | |
| SCHEMBL2364662 | 0.75 | DRD1 (0.40) | DRD1 | |
| SCHEMBL30367805 | 0.74 | GABBR2 (0.37) | GABBR2GABBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124805-B2 | Allyl acetate hydroformylation process | LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) | 2012-02-28 | — | — | US | disclosed |
| US-20110124904-A1 | Allyl acetate hydroformylation process | LYONDELL CHEMICAL TECHNOLOGY, L.P. | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124904-A1 | Allyl acetate hydroformylation process | GNPAT, DHPS, ALDH3A1 | DRD1 2526/4885GABBR2 1585/4885GABBR1 1972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.